Furthermore, the bmaC defective mutant was outcompeted by the wild-type strain in co-infection experiments, and anti-BmaC and anti-fibronectin antibodies significantly inhibited the binding of B. suis to HeLa cells [67]. Here, CXCL14 is linked to infection.